Join to View Full Profile
1801 W TaylorOCC 1EChicago, IL 60612
Phone+1 312-355-1625
Dr. Salahudeen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health CareFellowship, Hematology and Medical Oncology, 2013 - 2018
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2011 - 2013
University of Texas Southwestern Medical SchoolClass of 2011
Certifications & Licensure
CA State Medical License 2013 - 2027
IL State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Phase II Trial of Regorafenib and Oral Methotrexate in Previously Treated Advanced-Mutant NSCLC.Jacqueline V Aredo, Heather A Wakelee, Kavitha J Ramchandran, Joel W Neal, Maximilian Diehn
JTO Clinical and Research Reports. 2024-12-01 - 3 citationsDetecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities.Ariane Lozac'hmeur, Tyler Danek, Qidi Yang, Mario G Rosasco, John S Welch
NPJ Precision Oncology. 2024-08-05 - 4 citationsFunctional screening of amplification outlier oncogenes in organoid models of early tumorigenesis.Ameen A Salahudeen, Jose A Seoane, Kanako Yuki, Amanda T Mah, Amber R Smith
Cell Reports. 2023-11-28
Press Mentions
Stanford Researchers Map Intricacies of Lung Cancer in One of Their OwnMay 3rd, 2018
A Blood Test to Help Detect Lung Cancer? New Test Offered at OSF Healthcare Part of Trend in MedicineMay 14th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
